Fisher Wallace Labs develops, validates, and commercializes wearable brain stimulation technology for the treatment of anxiety, depression, insomnia, and other neuropsychiatric and cognitive disorders, with a self-described mission to increase access to rapid and safe mental healthcare.

Fisher Wallace Labs

Fisher Wallace Laboratories, Inc. | 1,192 followers on LinkedIn. Better tech for mental health. | Fisher Wallace Labs is on a mission to vastly increase access to mental healthcare. We develop and commercialize wearable brain stimulation technology for the treatment of depression, anxiety, and other neuropsychiatric and cognitive disorders. Our technology was recently proven to be rapidly effective in two large clinical trials for the treatment of Major Depressive Disorder and Generalized Anxiety Disorder, the latter of which was conducted in collaboration with the Seattle Police Department and Washington State University.

Ursus Advisory

Chip Fisher

Entrepreneur | Sales Leader | Team Builder

Yedidiah Teitelbaum

Chief Legal Officer | General Counsel | Strategic Business Partner | Investor | Board Member

Alexandra Bulkeley

Kelly Roman

Fisher Wallace Laboratories, Inc.

A big step towards improving how depression is treated:

On January 2nd, Fisher Wallace welcomed Dr. Maurizio Fava as an advisor to design the clinical trial we intend to conduct later this year to obtain FDA approval for the treatment of depression. Dr. Fava serves as Psychiatrist-in-Chief at Massachusetts General Hospital, and is also Director of the Mass General Research Institute. We are honored to have him as a collaborator as we work to make safe, rapid depression treatment accessible to everyone. The new protocol will be informed, in part, by our recent 255-subject study that documented the acute (4 week) treatment of moderate to severe depression, the results of which will soon be published by The Journal of Clinical Psychiatry. We intend to submit these results in support of a CE mark and UKCA mark for OAK.

Metric
Company Name	Fisher Wallace Labs
Symbol
MSH ID	COM:FISHERWALLACE
Market	PRIVATE
Sector	Healthcare & Health Services
Industry	Mental Health Technology
Country	US
Stage
Employee Count
Website	fisherwallace.com
LinkedIn	fisher-wallace-laboratories
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

FISH

COM:FISHERWALLACE

Fisher Wallace Labs

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue